Cargando…

Inhibition of Neuraminidase Inhibitor-Resistant Influenza Virus by DAS181, a Novel Sialidase Fusion Protein

Antiviral drug resistance for influenza therapies remains a concern due to the high prevalence of H1N1 2009 seasonal influenza isolates which display H274Y associated oseltamivir-resistance. Furthermore, the emergence of novel H1N1 raises the potential that additional reassortments can occur, result...

Descripción completa

Detalles Bibliográficos
Autores principales:	Triana-Baltzer, Gallen B., Gubareva, Larisa V., Klimov, Alexander I., Wurtman, David F., Moss, Ronald B., Hedlund, Maria, Larson, Jeffrey L., Belshe, Robert B., Fang, Fang
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2009
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2770896/ https://www.ncbi.nlm.nih.gov/pubmed/19893749 http://dx.doi.org/10.1371/journal.pone.0007838

Ejemplares similares

Novel Pandemic Influenza A(H1N1) Viruses Are Potently Inhibited by DAS181, a Sialidase Fusion Protein
por: Triana-Baltzer, Gallen B., et al.
Publicado: (2009)

A Safety Evaluation of DAS181, a Sialidase Fusion Protein, in Rodents
por: Larson, Jeffrey L., et al.
Publicado: (2011)

Antibody against Microbial Neuraminidases Recognizes Human Sialidase 3 (NEU3): the Neuraminidase/Sialidase Superfamily Revisited
por: Feng, Chiguang, et al.
Publicado: (2017)

Neuraminidase inhibitor susceptibility surveillance of influenza viruses circulating worldwide during the 2011 Southern Hemisphere season
por: Okomo‐Adhiambo, Margaret, et al.
Publicado: (2013)

Neuraminidase Inhibitor Susceptibility Testing in Human Influenza Viruses: A Laboratory Surveillance Perspective
por: Okomo-Adhiambo, Margaret, et al.
Publicado: (2010)

Neuraminidase-1: A Sialidase Involved in the Development of Cancers and Metabolic Diseases
por: Toussaint, Kévin, et al.
Publicado: (2022)

Trypanosoma cruzi trans-sialidase and neuraminidase activities can be mediated by the same enzymes
Publicado: (1992)

The use of sialidase therapy for respiratory viral infections
por: Nicholls, John M., et al.
Publicado: (2013)

An Investigational Antiviral Drug, DAS181, Effectively Inhibits Replication of Zoonotic Influenza A Virus Subtype H7N9 and Protects Mice From Lethality
por: Marjuki, Henju, et al.
Publicado: (2014)

A broadly protective human monoclonal antibody targeting the sialidase activity of influenza A and B virus neuraminidases
por: Yasuhara, Atsuhiro, et al.
Publicado: (2022)

Successful Treatment of Parainfluenza Virus Respiratory Tract Infection With DAS181 in 4 Immunocompromised Children
por: Waghmare, Alpana, et al.
Publicado: (2015)

Influenza B Viruses with Mutation in the Neuraminidase Active Site, North Carolina, USA, 2010–11
por: Sleeman, Katrina, et al.
Publicado: (2011)

Correction: Okomo-Adhiambo, M. et al. Neuraminidase Inhibitor Susceptibility Testing in Human Influenza Viruses: A Laboratory Surveillance Perspective. Viruses 2010, 2, 2269–2289
por: Okomo-Adhiambo, Margaret, et al.
Publicado: (2011)

Amino acid determinants conferring stable sialidase activity at low pH for H5N1 influenza A virus neuraminidase
por: Takahashi, Tadanobu, et al.
Publicado: (2012)

DAS181 Treatment of Severe Parainfluenza Virus 3 Pneumonia in Allogeneic Hematopoietic Stem Cell Transplant Recipients Requiring Mechanical Ventilation
por: Dhakal, B., et al.
Publicado: (2016)

The Function of Sialidase Revealed by Sialidase Activity Imaging Probe
por: Minami, Akira, et al.
Publicado: (2021)

H9N2 Influenza Virus Infections in Human Cells Require a Balance between Neuraminidase Sialidase Activity and Hemagglutinin Receptor Affinity
por: Arai, Yasuha, et al.
Publicado: (2020)

Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2013–2014
por: Takashita, Emi, et al.
Publicado: (2015)

Design of Trypanosoma rangeli sialidase mutants with improved trans-sialidase activity
por: Nyffenegger, Christian, et al.
Publicado: (2017)

Influenza neuraminidase
por: Air, Gillian M.
Publicado: (2011)

Cerebrospinal fluid p-tau217 performs better than p-tau181 as a biomarker of Alzheimer’s disease
por: Janelidze, Shorena, et al.
Publicado: (2020)

Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2015–2016
por: Gubareva, Larisa V., et al.
Publicado: (2017)

Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2012–2013
por: Meijer, Adam, et al.
Publicado: (2014)

An optimized cell-based assay to assess influenza virus replication by measuring neuraminidase activity and its applications for virological surveillance
por: Patel, Mira C., et al.
Publicado: (2022)

Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2014–2015
por: Hurt, Aeron C., et al.
Publicado: (2016)

Imaging of influenza virus sialidase activity in living cells
por: Kurebayashi, Yuuki, et al.
Publicado: (2014)

Study of Neuraminidase-Inhibiting Antibodies in Clinical Trials of Live Influenza Vaccines
por: Desheva, Yulia, et al.
Publicado: (2020)

Antiviral Drug–Resistant Influenza B Viruses Carrying H134N Substitution in Neuraminidase, Laos, February 2016
por: Baranovich, Tatiana, et al.
Publicado: (2017)

Antiviral Strategies for Pandemic and Seasonal Influenza
por: Hedlund, Maria, et al.
Publicado: (2010)

Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors and status of novel antivirals, 2016–2017
por: Lackenby, Angie, et al.
Publicado: (2018)

Sialidase Inhibitors with Different Mechanisms
por: Keil, Joseph M., et al.
Publicado: (2022)

Visualization of Sialidase Activity in Mammalian Tissues and Cancer Detection with a Novel Fluorescent Sialidase Substrate
por: Minami, Akira, et al.
Publicado: (2014)

Increased sialidase activity in serum of cancer patients: Identification of sialidase and inhibitor activities in human serum
por: Hata, Keiko, et al.
Publicado: (2015)

A neuraminidase potency assay for quantitative assessment of neuraminidase in influenza vaccines
por: Byrne-Nash, Rose T., et al.
Publicado: (2019)

Consecutive influenza surveillance of neuraminidase mutations and neuraminidase inhibitor resistance in Japan
por: Chong, Yong, et al.
Publicado: (2019)

Predictive Markers of Efficacy for an Angiopoietin-2 Targeting Therapeutic in Xenograft Models
por: Triana-Baltzer, Gallen, et al.
Publicado: (2013)

Resolution of Coronavirus Disease 2019 Infection and Pulmonary Pathology With Nebulized DAS181: A Pilot Study
por: Ho, Jennifer Hui-Chun, et al.
Publicado: (2020)

Contribution of Neuraminidase of Influenza Viruses to the Sensitivity to Sera Inhibitors and Reassortment Efficiency
por: Kiseleva, Irina, et al.
Publicado: (2014)

Sialidases on Mammalian Sperm Mediate Deciduous Sialylation during Capacitation
por: Ma, Fang, et al.
Publicado: (2012)

Anomeric 1,2,3-triazole-linked sialic acid derivatives show selective inhibition towards a bacterial neuraminidase over a trypanosome trans-sialidase
por: de Andrade, Peterson, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4075g037aot5j83ta29gl9pbam